Scientists find immune drug that could halt skin cancer’s deadly spread

A major clinical study by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has found that an immune-based cancer drug may help reduce the spread of Merkel cell carcinoma, a rare but aggressive type of skin cancer, when used soon after surgery. The phase 3 STAMP trial (EA6174) tested…

Click here to view the original article.